Format

Send to

Choose Destination
Lancet. 2014 Dec 20;384(9961):2175-6. doi: 10.1016/S0140-6736(14)61457-4. Epub 2014 Dec 19.

Cancer nanomedicines: closing the translational gap.

Author information

1
Shaare Zedek Medical Center and Hebrew University-School of Medicine, Jerusalem, Israel.
2
Sloan Kettering Institute for Cancer Research and Weill Medical College of Cornell University, New York, NY, USA.
3
Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, MD 20892, USA.
4
UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
5
Albert Einstein College of Medicine, New York, NY, USA.
6
Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: grodzinp@mail.nih.gov.
PMID:
25625382
PMCID:
PMC6615547
DOI:
10.1016/S0140-6736(14)61457-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center